The present invention provides a therapeutic agent for bile duct cancer comprising 5 - ((2- (4- (1- (2-hydroxyethyl) piperidin-4-yl) benzamide) pyridin-4-yl) oxy) -6- ( 2-methoxyethoxy) -n-methyl-1h-indole-1-carboxamide or a pharmacologically acceptable salt thereof.AKIHIKO TSURUOKA...
Management of cancer of the bile duct. Tumors of the bile duct are uncommon. Most patients will present with a syndrome of obstructive jaundice, but in a few patients the tumor can mimic benign ... RL Rossi,FW Heiss,CF Beckmann,... - 《Surgical Clinics of North America》 被引量: 272...
Bile duct andgallbladder tumorsare invasiveadenocarcinomasthat arise from extrahepatic and intrahepatic bile ducts or the epithelial lining of the gallbladder (Kawamoto et al., 2007). Due to late diagnosis and lack of palliative care and adequate treatment methods, the prognosis of bile duct tumors...
Noncurative resection occurred frequently for cancers at all sites, particularly in cancers of the hilar or upper bile duct, accounting for 60% of cases or more. We have to recognize that measures to reduce inadvertent noncurative resection are fundamental to the treatment of cancer.Conclusions: ...
been thoroughly elucidated to offer valuable insights into the potential of TCM for anti-cancer drug discovery. We emphasized the importance of further research to bridge the gap between TCM and modern oncology, facilitating the development of evidence-based TCM treatment for these challenging ...
Bile duct cancer, in the early stage, usually does not have any observable symptoms. In the advanced stage, however, symptoms include yellowing skin and eyes etc
Most effective herbal treatment for Cancer and herbs for Cancer. Causes and Symptoms of Cancer. Herbal treatment of Cancer by natural herbs is given in repertory format.
Surgical resection is the only treatment with curative intent for GBC but very few cases are suitable for resection and most adjuvant therapy has a very low response rate. Several unmet clinical needs require to be addressed to improve GBC management, including discovery and validation of reliable ...
The European Commission has approved the oraltargeted therapypemigatinib(Pemazyre) for the treatment of locally advanced or metastaticcholangiocarcinoma, a rare cancer of the bile ducts. The indication is for patients with a fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that have...
In the present study, the outcomes of surgical treatment were better than that of the previous report from Japan and foreign countries. The pT, pN and stage of gallbladder cancer are well defined. However, there were no significant differences in some groups of those of bile duct cancer and...